Immix Biopharma, Inc. (IMMX) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
AD
Currency In USD
| Market Cap | 172.41M |
| Enterprise Value | 79.56M |
| P/E Ratio | -10.22 |
| PEG Ratio | 0.41 |
| Price/Sales Ratio | 0 |
| Price/Book Ratio | 4.27 |
| Enterprise/Revenue | 0 |
| Enterprise/EBITDA | -12.53 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | March 31, 2026 |
| Profit Margin | 0 |
| Operating Margin | 0 |
| Return On Assets | -0.37 |
| Return On Equity | -0.73 |
| Revenue | 0 |
| Revenue/Share | 0 |
| Gross Profit | -364,501 |
| EBITDA | -29.04M |
| Net Income | -29.44M |
| Diluted EPS | -0.89 |
| Total Cash | 90.58M |
| Total Cash/Share | 2.37 |
| Total Debt | 1.04M |
| Total Debt/Equity | 0.01 |
| Current Ratio | 8.76 |
| Book Value Per Share | 2.2 |
| 52-Week Change | 321.52 |
| 52-Week High | 11.61 |
| 52-Week Low | 1.94 |
| Moving Average 50 Days | 9.23 |
| Moving Average 200 Days | 6.3 |
| Average Volume | 1.15M |
| Shares Outstanding | 54.4M |
| % Held by Institutions | 70.72 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |